Omeros Stock

Omeros Enterprise Value

The Enterprise Value (EV) of Omeros (OMER) as of Aug 14, 2026 is 657.02 M USD. In the previous year, Enterprise Value (EV) was 1.14 B USD — a change of -42.59% (lower).

Enterprise Value

657.02 MUSD

YoY

-42.59%

Last updated:

Enterprise Value (EV) of Omeros is 2026 657.02 M USD. Enterprise Value (EV) of Omeros was 2025 1.14 B USD. It decreases by -42.59% lower compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Enterprise Value (EV) of Omeros is 657.02 M USD in 2026.

Enterprise Value (EV) of Omeros changed from 1.14 B USD to 657.02 M USD, representing a -42.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Omeros since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Omeros with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Omeros

All Key Metrics — Omeros